← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 17, 2018Last known activity
Apr 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (5)
- NCT05271929Lead sponsorPhase 3Apr 1, 2022
- NCT04433910Lead sponsorPhase 2Jun 30, 2020
- NCT04433910Study directorPhase 2Jun 30, 2020
- NCT04433910Overall official - principal investigatorPhase 2Jun 30, 2020
- NCT03561909CollaboratorN/AApr 17, 2018
Details
- Last known activity
- Apr 1, 2022